Influence of interleukin-1β on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice

Psychopharmacology

Volumn 137, Issue 4, 1998, Pages 351-361

  Lacosta, Susan ^a   Merali, Zul ^b   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

ACTH; Anxiety; Corticosterone; Cytokine; Dopamine; Exploration; Norepinephrine; Serotonin; Spontaneous alternation

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; DOPAMINE; INTERLEUKIN 1BETA; NORADRENALIN; BIOGENIC AMINE; INTERLEUKIN 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN METABOLISM; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DOPAMINE BRAIN LEVEL; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; TASK PERFORMANCE; ANIMAL; BLOOD; BRAIN LEVEL; DOSE RESPONSE; DRUG EFFECT; MOTOR ACTIVITY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BIOGENIC AMINES; BRAIN CHEMISTRY; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; INTERLEUKIN-1; MALE; MICE; MOTOR ACTIVITY;

EID: 0031595002     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050630     Document Type: Article

References (52)

1. Anisman H, Zalcman S, Zacharko RM (1993) The impact of stressors on immune and central neurotransmitter activity: bidirectional communication. Rev Neurosci 4: 147-180
2. Berkenhosch F, de Rijk R, del Rey A, Besedovsky H (1990) Neuroendocrinology of interleukin-1. In: Porter JC, Jezova D (eds) Circulating regulatory factors and neuroendocrine function. Plenum Press, New York, pp 303-314
3. Blalock JE (1994) The syntax of immune-endocrine communication. Immunol Today 15: 504-544
4. Bluthe RM, Dantzer R, Kelley KW (1989) Corticotropin releasing hormone is not involved in the behavioral effects of peripherally injected interleukin-1 in the rat. Neurosci Res Commun 5: 149-154
5. Bluthe RM, Michaud B, Kelley KW, Dantzer R (1996) Vagotomy attenuates behavioral effects of interleukin-1 injected peripherally but not centrally. Neuroreport 7: 1485-1488
6. Bret-Dibat JL, Bluthe RM, Kent S, Kelley KW, Dantzer, R (1995) Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun 9: 242-246
7. Carmelia G, Pietro G, De Simoni MG (1991) Activation of the hypothalamic serotonergic system by central interleukin-1. Eur J Pharmacol 209: 139-140
8. Chiueh CC, Zukowska-Grojec Z, Kirk KL, Kopin JJ (1983) 6-Fluorocatecholamine as a false adrenergic neurotransmitter. J Pharmacol Exp Ther 225: 529-533
9. Connor TJ, Song C, Leonard BE, Merali Z, Anisman H (1998) Comparative effects of IL-1β, -2, -6, and tumor necrosis factor -α administration on some behavioral, neurochemical, endocrine and immune parameters. Neuroscience (in press)
10. Crestani F, Seguy F, Dantzer R (1991) Behavioral effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res 542: 330-334
11. Dantzer R, Kelley KW (1989) Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 44: 1995-2008
12. Dantzer R, Bluthe RM, Aubert A, Goodall G, Bret-Dibat J-L, Kent S, Goujon E, Laye S, Parnet P, Kelley KW (1996) Cytokine actions on behavior. In: Rothwell NJ (ed) Cytokines and the nervous system. Landes, London, pp 117-144
13. Deutch AY, Roth RH (1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. In: Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP (eds) Progress in brain research. Elsevier, New York, vol 85, pp 367-403
14. Dunn AJ (1988) Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci 43: 429-435
15. Dunn AJ (1990) Interleukin-1 as a stimulator of hormone secretion. Prog Neuroendocrin Immunol 3: 26-34
16. Dunn AJ (1995) Interactions between the nervous system and the immune system. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press New York, pp 719-731
17. Dunn AJ, Antoon M, Chapman Y (1991) Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor. Brain Res Bull 26: 539-542
18. Farrar WL, Kilian PL, Ruff M, Hill JM, Pert CB (1987) Visualization and characterization of interleukin-1 receptors in brain. J Immunol 139: 459-463
19. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego, Calif
20. Gemma C, Ghezzi P, De Simoni MG (1991) Activation of the hypothalamic serotonergic system by central interleukin-1. Eur J Pharmacol 209: 139-140
21. Gray TS (1991) Amygdala: role in autonomic and neuroendocrine responses to stress. In: McCuhhin JA, Kaufmann PG, Nemeroff CB (eds) Stress, neuropeptides and systemic disease. Academic Press, New York, pp 37-53
22. Heilig M, Kooh GF, Ekman R, Britton KT (1994) Corticotropin releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17: 80-84
23. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA (1989) Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 84: 228-235
24. Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20: 78-84
25. Hopkins SJ, Rothwell NJ (1995) Cytokines and the nervous system I. Expression and recognition. Trends Neurosci 18: 83-88
26. Imura H, Fukata J-I, Mori T (1991) Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems. Clin Endocrinol 35: 107-115
27. Kabiersch A, Del Rey A, Honegger CG, Besedovsky HO (1988) Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 2: 267-274
28. Katsuura G, Gottschall PE, Arimura A (1988) Identification of a high-affinity receptor for interleukin-1 beta in rat brain. Biochem Biophys Res Commun 156: 61-67
29. Kent S, Bluthe R-M, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13: 24-28
30. Koenig JI (1991) Presence of cytokines in the hypothalamic-pituitary axis. Prog Neuroendocrin Immunol 4: 143-153
31. Kokkinidis L, Anisman H (1981) Amphetamine psychosis and schizophrenia: a dual model. Neurosci Biobehav Rev 5: 449-461
32. Krueger JM, Takahashi S, Kapas L, Bredow S, Roky R, Fang J, Floyd R, Renegar KB, Guha-Thakurta N, Novitsky S, Obal F (1995) Cytokines in sleep regulation. Adv Neuroimmunol 5: 171-188
33. Lacosta S, Merali Z, Zalcman S, Anisman H (1994) Time-dependent in vivo mesolimbic dopamine variations following antigenie challenge. Brain Res 664: 225-230
34. Lacosta S, Kulczycki J, Merali Z, Anisman H (1996) Behavioral, endocrine and central neurochemical alterations induced by interleukin-1. Soc Neurosci Abstr 22: 2059
35. Linthorst ACE, Flachskamm C, Muller-Preuss P, Holsboer F, Reul JMHM (1995) Effect of bacterial endotoxin and interleukin-1 on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J Neurosci 15: 2920-2934
36. McCarthy DO, Kluger MJ, Vander AJ (1985) The role of interleukin-1 in the suppression of food intake during infection. Am J Clin Nutr 42: 1179-1182
37. Mefford IN, Heyes MP (1990) Increased biogenic amine release in mouse hypothalamus following immunological challenge: antagonism by indomethacin. J Neuroimmunol 27: 55-61
38. Merali Z, Lacosta S, Anisman H (1997) Effects of interleukin-1 and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res 761: 225-235
39. Mohankumar PS, Quadri SK (1993) Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sci 52: 1961-1967
40. Mohankumar PS, Thyagarajan S, Quadri SK (1991) Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from hypothalamus in vivo. Life Sci 48: 925-930
41. Mohankumar PS, Thyagarajan S, Quadri SK (1993) Interleukin-1β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo. Brain Res Bull 31: 745-748
42. Moldofsky H (1995) Sleep and the immune system. Int J Immunopharmacol 17: 649-654
43. Palkovits M, Brownstein MJ (1988) Maps and guide to microdissection of the rat brain. Elsevier, New York
44. Payne LC, Obal F, Krueger JM (1993) Hypothalamic releasing hormones mediating the effects of interleukin-1 on sleep. J Cell Biochem 53: 309-313
45. Plata-Salaman CR (1989) Immunomodulators and feeding regulation: a humoral link between the immune and nervous systems. Brain Behav Immun 3: 193-213
46. Plata-Salaman CR (1994) Meal patterns in response to the intracerebroventricular administration of interleukin-1β in rats. Physiol Behav 55: 727-733
47. Rivier C (1995) Influence of immune signals on the hypothalamicpituitary axis of the rodent. Front Neuroendocrinol 16: 151-182
48. Rothwell NJ (1991) Functions and mechanisms of interleukin-1β in the brain. Trends Pharmacol Sci 12: 430-436
49. Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E, Yagi G, Kato R, Asai M (1993) Interleukin-1β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus. J Neurosci 13: 3574-3581
50. Spadaro F, Dunn AJ (1990) Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a new environment. Brain Behav Immun 4: 308-322
51. Watkins LR, Maier SF, Goehler LE (1995) Cytokine-to brain-communication: a review and analysis of alternative mechanisms. Life Sci 11: 1011-1026
52. Zalcman S, Green-Johnson J, Murray L, Nance DM, Dyck D, Anisman H, Greenberg A (1994) Cytokine-specific central monoamine alterations induced by interleukin (IL)-1, (IL)-2 and (IL)-6. Brain Res 643: 40-99